{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:31Z","timestamp":1792790491385,"version":"4.5.0"},"reference-count":50,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T00:00:00Z","timestamp":1268265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic>\u2002<jats:bold>31<\/jats:bold>, 1155\u20131164<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Travellers\u2019 diarrhoea, a common problem worldwide with significant medical impact, is generally treated with anti\u2010diarrhoeal agents and fluid replacement. Systemic antibiotics are also used in selected cases, but these may be associated with adverse effects, bacterial resistance and drug\u2013drug interactions.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To review the clinical evidence supporting the efficacy and safety of the minimally absorbed oral antibiotic rifaximin in travellers' diarrhoea.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> PubMed and the Cochrane Register of Controlled Clinical Trials (to January 2010) and International Society of Travel Medicine congress abstracts (2003\u20132009) were searched to identify relevant publications.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> A total of 10 publications were included in the analysis. When administered three times daily for 3\u2003days, rifaximin is superior to placebo or loperamide; it is at least as effective as ciprofloxacin in reducing duration of illness and restoring wellbeing in patients with travellers' diarrhoea, both with and without identification of a pathogen, as well as in diarrhoea caused by <jats:italic>Escherichia coli<\/jats:italic> infection. Rifaximin demonstrates only minimal potential for development of bacterial resistance and for cytochrome P450\u2010mediated drug\u2013drug interactions, and its tolerability profile is similar to that of placebo.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> When antibiotic therapy is warranted in uncomplicated travellers' diarrhoea, rifaximin may be considered as a first\u2010line treatment option because of its favourable efficacy, tolerability and safety profiles.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04296.x","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T00:55:00Z","timestamp":1273020900000},"page":"1155-1164","source":"Crossref","is-referenced-by-count":23,"title":["Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers\u2019 diarrhoea"],"prefix":"10.1111","volume":"31","author":[{"given":"P.","family":"LAYER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"ANDRESEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70139-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.9.811"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2000.62.585"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/432948"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/315397"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04028.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/432956"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/507540"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/318119"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00282-0"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/510589"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/320756"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/338834"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(01)00303-0"},{"key":"e_1_2_6_16_2","first-page":"CD002242","article-title":"Antibiotic treatment for travellers\u2019 diarrhea","volume":"3","author":"De Bruyn G","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306243282507"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.6.956"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2600-2603.2000"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057839"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921050-00005"},{"key":"e_1_2_6_22_2","first-page":"20","article-title":"Fluoroquinolones: psychiatric adverse effects","volume":"17","year":"2008","journal-title":"Prescrire Int"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1722"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.spid.2004.01.009"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0802.010145"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/423282"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2007.07.003"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.4.515"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2668"},{"key":"e_1_2_6_30_2","first-page":"5","article-title":"Quinolone\u2010resistant Escherichia coli","volume":"12","author":"Sanches Ito CA","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.643-644.2001"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/323814"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.212-216.2001"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01623-06"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050426"},{"key":"e_1_2_6_36_2","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin","volume":"12","author":"De LeoC","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007297"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03647.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007580"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1572-0241.2003.07283.x","article-title":"Therapy of travelers\u2019 diarrhea with rifaximin on various continents","volume":"98","author":"Steffen R","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00322-7"},{"key":"e_1_2_6_42_2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2006.74.1060","article-title":"A randomized, double\u2010blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of traveler\u2019s diarrhea","volume":"74","author":"Taylor DN","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2006.00084.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.02.004"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-10-200505170-00005"},{"issue":"2","key":"e_1_2_6_46_2","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.14309\/00000434-200609001-00457","article-title":"Prevention of travelers\u2019 diarrhea with rifaximin \u2013 a phase 3 randomized double\u2010blind placebo\u2010controlled trial in U.S. students in Mexico","volume":"101","author":"DuPont HL","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00997.x"},{"key":"e_1_2_6_48_2","first-page":"51","article-title":"Pharmacokinetic study of rifaximin after oral administration in healthy volunteers","volume":"14","author":"Descombe JJ","year":"1994","journal-title":"Int J Clin Pharm Res"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2205-2206.2000"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H395"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.10.1361"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04296.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04296.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T15:26:27Z","timestamp":1698765987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04296.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,3]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04296.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04296.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,3]]}}}